Close

Rating History for CRISPR Therapeutics (CRSP) by JMP Securities

More Stocks Rated by JMP Securities | Latest Ratings for CRSP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/13/2024 Silvan Tuerkcan Maintain Market Outperform
(N/A)		 86.00
(80.00)		  
 		   Details